Trials / Completed
CompletedNCT00127153
A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)
A Comparative Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of V110 Formulated With Either All New Process Polysaccharides or All Current Process Polysaccharides
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (planned)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this trial is to evaluate the safety, tolerability, and immunogenicity of an investigational pneumococcal vaccine in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | V110, pneumococcal vaccine polyvalent |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2005-08-05
- Last updated
- 2015-01-29
Source: ClinicalTrials.gov record NCT00127153. Inclusion in this directory is not an endorsement.